CPHI AMEX
China Pharma Holdings, Inc.
1W: -14.7%
1M: -24.1%
3M: -6.1%
YTD: -47.0%
1Y: -67.0%
3Y: -90.8%
5Y: -99.8%
$0.66
+0.00 (+0.61%)
Weekly Expected Move ±8.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-11-23
Earliest Filing
2022-12-02
Latest Filing
partner: 2
investor: 1
Counterparties (Filed by CPHI)
3 relationshipsCompanies named in CPHI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Hainan Helpson Medical & Biotechnology Co., Ltd | — | partner | Wholly owned subsidiary of China Pharma Holdings, Inc. that entered into a Technology Transfer Contract to acquire paten | 2022-12-02 | View |
| Chengdu Bonier Medical Technology Development Co., Ltd | — | partner | Provider of ophthalmic oxygen enriched atomization therapeutic instrument patents and technical services in exchange for | 2022-12-02 | View |
| Streeterville Capital, LLC | — | investor | Institutional accredited investor that purchased a convertible promissory note from the Company. | 2021-11-23 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-22 | Material Agreement; Other Events; Exhibits | Agreement | View |
| 2026-03-03 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-02-10 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-01-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-12-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities | Agreement | View |
| 2025-12-10 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities | Agreement | View |
| 2025-04-04 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-26 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-12-26 | Termination of Material Definitive Agreement | View | |
| 2024-12-13 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-05-08 | Changes in Registrant's Certifying Accountant | View | |
| 2024-03-29 | Other Events | View | |
| 2024-02-23 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-02-08 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities | Agreement | View |
| 2023-12-21 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities | Agreement | View |
| 2023-12-19 | Submission of Matters to a Vote of Security Holders; Other Events | View | |
| 2023-10-03 | Notice of Delisting or Transfer | View | |
| 2023-03-29 | Other Events | View | |
| 2023-02-24 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2022-12-30 | Submission of Matters to a Vote of Security Holders | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR